Global Particle Size Analysis Market 2014-2018

2014-07-14
Price :
Published : Jul-2014
No. of Pages : 60

Particle size analysis is a technique used to determine the size of a particle in a material such as powder or liquid. It is crucial to analyze the size of particles as it can affect the functionality of the material. Therefore, particle size analysis is performed to determine the behavior and nature of a material, and for its effective functioning (performance and stability). Particle size analysis is used in numerous industries such as Healthcare, Chemical, Mining, and Agriculture.

TechNavio’s analysts forecast the Global Particle Size Analysis market will grow at a CAGR of 5.01 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Particle Size Analysis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of particle size analyzers worldwide.

TechNavio’s report, the Global Particle Size Analysis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region, and the ROW; it also covers the Global Particle Size Analysis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • North America
  • Europe
  • APAC
  • ROW

Key Vendors

  • Beckman Coulter Inc.
  • HORIBA Ltd.
  • Malvern Instruments Ltd.
  • Micromeritics Instrument Corp.
  • Microtrac Inc.

Other Prominent Vendors

  • Agilent Technologies Inc.
  • Izon Ltd.
  • Shimadzu Corp.
  • Sympatec GmbH

Key Market Driver

  • Increasing Applications of Nanotechnology
  • For a full, detailed list, view our report.

Key Market Challenge

  • Intense Competitive Environment
  • For a full, detailed list, view our report.

Key Market Trend

  • Increase in Collaborations
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Bacterial Vaginosis Global Clinical Trials Review, H2, 2017

Bacterial Vaginosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2017" provides an overview of Bacterial Vaginosis clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Vaginosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinic......
$2500

Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017

Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017" provides an overview of Postmenopausal Vaginal Atrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Postmenopausal Vaginal Atrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
$2500

Nocturia Global Clinical Trials Review, H2, 2017

Nocturia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Nocturia Global Clinical Trials Review, H2, 2017" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017

Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Hormone Deficiency Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Deficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Bladder Cancer Global Clinical Trials Review, H2, 2017

Bladder Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017

Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Female Hypoactive Sexual Desire Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial ......
$2500

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Charles River Laboratories International Inc (CRL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical support, manufacturing support and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to global pharmaceutical companies, biotechnology companies, government agencies, as well as leading hospitals and academic institutions, ......
$250

Incyte Corp (INCY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Incyte Corp (Incyte) is a biopharmaceutical company that discovers, develops, and commercializes proprietary cancer therapeutics. The company's lead product, Jakafi (ruxolitinib) is marketed in the US for the treatment of patients with high-risk myelofibrosis as well as patients with polycythemia vera who are intolerant to hydroxyurea. JAKAFI is distributed principally through a network of specialty pharmacy providers and wholesalers. In collaboration with Incyte, Novartis International Pharmaceutical Ltd. (Norvatis) develops and commercializes ruxolitinib outside the US for hematologic and oncologic indications under the name Jakavi. The company's pipeline portfolio encompasses drug indications targeted at the treatment of lung cancer, graft versus host disease, non-small cell lu......
$250